Stéphane Postic
Director of Finance/CFO at MEDINCELL S.A.
Profile
Stéphane Postic is currently the Chief Executive Officer at Da Volterra SA since 2022 and the Chief Financial Officer at MedinCell SA since 2023.
Previously, he worked as a Director at GDSA SA and as the Chief Financial Officer at Genfit SA from 2002 to 2010.
Stéphane Postic active positions
Companies | Position | Start |
---|---|---|
MEDINCELL S.A. | Director of Finance/CFO | 01/09/2023 |
Da Volterra SA
Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | Chief Executive Officer | 06/09/2022 |
Former positions of Stéphane Postic
Companies | Position | End |
---|---|---|
GDSA SA
GDSA SA Wholesale DistributorsDistribution Services GDSA SA designs and manufactures industrial tools and provides maintenance services and development of processes for the automobile, aeronautics and railway industries. It offers engineering services, tool manufacturing, and on-site tool installation. The company was founded on August 18, 1982 and is headquartered in Saint-Denis, France. | Director/Board Member | - |
GENFIT | Director of Finance/CFO | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
GENFIT | Health Technology |
MEDINCELL S.A. | Health Technology |
Private companies | 2 |
---|---|
GDSA SA
GDSA SA Wholesale DistributorsDistribution Services GDSA SA designs and manufactures industrial tools and provides maintenance services and development of processes for the automobile, aeronautics and railway industries. It offers engineering services, tool manufacturing, and on-site tool installation. The company was founded on August 18, 1982 and is headquartered in Saint-Denis, France. | Distribution Services |
Da Volterra SA
Da Volterra SA BiotechnologyHealth Technology Da Volterra develops a portfolio of products in the antibacterial field, with a specific focus on antibiotic resistance. Its productDAV132, developed to prevent the disruption of the intestinal microbiota and prevent Clostridium difficile infections associated with antibiotic use. The company was founded by Antoine Andremont in 2000 and is headquartered in Paris, France. | Health Technology |
- Stock Market
- Insiders
- Stéphane Postic